204 results
8-K
EX-10.1
75gtbbn t8
29 Feb 24
Departure of Directors or Certain Officers
4:30pm
424B5
9omtoo yy
17 Jan 24
Prospectus supplement for primary offering
7:18pm
8-K/A
cdw15h
23 Oct 23
Submission of Matters to a Vote of Security Holders
5:09pm
8-K
EX-3.1
jb9t72m9jm7lo6 wh
23 Oct 23
Amendments to Articles of Incorporation or Bylaws
5:01pm
8-K
bwvq452l
23 Oct 23
Amendments to Articles of Incorporation or Bylaws
5:01pm
8-K
EX-99.1
lavg4yqbnne7 o5v3
10 Jul 23
Vaxart Announces Positive Preliminary Topline Data from Dose-Ranging Phase 2 Study of its Bivalent Norovirus Vaccine Candidate
4:12pm
DEFA14A
24en7i1
21 Jun 23
Additional proxy soliciting materials
5:18pm
424B5
7hj4 dv1machowd
8 Jun 23
Prospectus supplement for primary offering
4:17pm
424B5
8cadr5zu 9lx0m2tki0k
6 Jun 23
Prospectus supplement for primary offering
5:21pm
424B5
wa2q66n v1j3nulumt
9 May 23
Prospectus supplement for primary offering
2:41pm